J004-1713 Screening compound: 3-ethyl-5-[1-(1-methyl-1H-pyrazole-5-carbonyl)pyrrolidin-2-yl]-1,2-oxazole

J004-1713 Screening compound: 3-ethyl-5-[1-(1-methyl-1H-pyrazole-5-carbonyl)pyrrolidin-2-yl]-1,2-oxazole
J004-1713 Screening compound: 3-ethyl-5-[1-(1-methyl-1H-pyrazole-5-carbonyl)pyrrolidin-2-yl]-1,2-oxazole alternative view

Chemical Structure Depiction of ChemDiv screening compound J004-1713
3-ethyl-5-[1-(1-methyl-1H-pyrazole-5-carbonyl)pyrrolidin-2-yl]-1,2-oxazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J004-1713

Molecular Formula

C14H18N4O2 (C14 H18 N4 O2)

Compound Name

3-ethyl-5-[1-(1-methyl-1H-pyrazole-5-carbonyl)pyrrolidin-2-yl]-1,2-oxazole

IUPAC name

3-ethyl-5-[1-(1-methyl-1H-pyrazole-5-carbonyl)pyrrolidin-2-yl]-12-oxazole

SMILES

CCc1noc(C(CCC2)N2C(c2ccnn2C)=O)c1

InChI

InChI=1S/C14H18N4O2/c1-3-10-9-13(20-16-10)11-5-4-8-18(11)14(19)12-6-7-15-17(12)2/h6-7,9,11H,3-5,8H2,1-2H3/t11-/m0/s1

InChI Key

YYNKLSWYNQEUDX-NSHDSACASA-N

MDL Number (MFCD)

MFCD27215103

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

274.32

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.200

Distribution Coefficient, logD

1.200

Water Solubility, LogSw

-1.87

Polar Surface Area

52.627

Acid Dissociation Constant (pKa)

23.79

Base Dissociation Constant (pKb)

1.50

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

50.00

J004-1713 in Drug Discovery

Included in Screening Libraries

Fragments Library (11262 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Structure:
  • Fragments
  • Cyclic compounds
Mechanism of action:
  • PPI modulators
  • PPI modulators
Therapeutical areas:
  • Cancer

References: we are preparing a list of scientific research reports with J004-1713 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J004-1713?
Check Price and Availability of J004-1713, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J004-1713 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J004-1713
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J004-1713
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J004-1713 available by request